InvestorPlace Earnings

InvestorPlace Earnings

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at editor@investorplace.com.

Recent Articles

SATS Stock Earnings: EchoStar Misses EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

SATS stock results show that EchoStar missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

AMRX Stock Earnings: Amneal Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024

By InvestorPlace Earnings

AMRX stock results show that Amneal Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

AIRS Stock Earnings: AirSculpt Technologies Beats EPS, Misses Revenue for Q2 2024

By InvestorPlace Earnings

AIRS stock results show that AirSculpt Technologies beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.

EMBC Stock Earnings: Embecta Beats EPS, Beats Revenue for Q3 2024

By InvestorPlace Earnings

EMBC stock results show that Embecta beat analyst estimates for earnings per share and beat on revenue for the third quarter of 2024.

TPST Stock Earnings: Tempest Therapeutics Misses EPS for Q2 2024

By InvestorPlace Earnings

TPST stock results show that Tempest Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.

Load More